Financial Highlights

Five-Year Summary

The Five-year summary is presented in pound sterling, rounded to the nearest million.

  IFRS 16   Pre-IFRS 16
INCOME STATEMENTS FY21
£'m		 FY20
£'m		 FY19
£'m		 FY18
£'m		 FY17
£'m
Revenue 2 995 3 083 2 932 2 876 2 749
Adjusted EBITDA 426 541 493 515 501
Operating (loss)/profit 209 (184) 81 (288) 362
Adjusted operating profit 221 327 330 370 360
Reported (loss)/earnings 68 (320) (151) (492) 229
Adjusted earnings 101 177 198 221 220

 

PER SHARE STATISTICS FY21
pence		 FY20
pence		 FY19
pence		 FY18
pence		 FY17
pence
Basic (loss)/earnings basis 9.2 (43.4) (20.5) (66.7) 31.0
Diluted (loss)/earnings basis 9.2 (43.4) (20.5) (66.7) 31.0
Basic adjusted earnings basis 13.7 24.0 26.9 30.0 29.8
Diluted adjusted earnings basis 13.7 24.0 26.9 30.0 29.8
Dividends declared per share - 3.20 7.90 7.90 7.90

 

STATEMENTS OF FINANCIAL POSITION FY21
£'m		 FY20
£'m		 FY19
£'m		 FY18
£'m		 FY17
£'m
ASSETS          
Non-current assets 5 440 5 741 5 337 5 382 6 353
Current assets 1 232 1 213 1 091 961 1 069
Total assets 6 6 72 6 954 6 428 6 343 7 422
 
EQUITY          
Owners of the parent 2 849 2 890 3 151 3 286 4 086
Non-controlling interest 118 113 115 87 78
Total equity 2 967 3 003 3 266 3 373 4 164
 
LIABILITIES          
Non-current liabilities 3 021 3 182 2 576 2 445 2 668
Current liabilities 684 769 586 525 590
Total liabilities 3 705 3 951 3 162 2 970 3 258
Total equity and liabilities 6 672 6 954 6 428 6 343 7 422

 

STATEMENTS OF CASH FLOWS FY21 FY20 FY19 FY18 FY17
Operating cash flow (£'m) 330 589 451 466 492
Adjusted EBITDA cash conversion (%) 77% 109% 91% 90% 98%

Email Alert Registration

Would you like to receive regular updates about Mediclinic International events and announcements? Then register for email alerts so we can send you all future updates directly.

Email Alerts